市场调查报告书
商品编码
1331405
切向流过滤市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测,按产品、膜材料、技术、按应用、最终用户、地区和竞争细分Tangential Flow Filtration Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Membrane Material, By Technique, By Application, By End User, By Region and By Competition |
预计全球切向流过滤市场在预测期内将出现令人印象深刻的增长。这可以归因于切向流过滤相对于正常流过滤的优势不断增强,以及一次性技术的日益采用以及製药和生物技术公司不断增长的研发。此外,TFF 技术在不同下游工艺中的使用不断增加预计将在预测期内推动市场的增长。此外,切向流过滤(TFF)在生物技术研究中用作高性能和可重复操作的优势以及各大公司对新型 TFF 产品开发的投资不断增加,正在推动预测期内市场的增长。 2021 年 9 月,为生物製药製造提供一次性集成解决方案和服务的主导企业 ABEC 宣布推出名为定制单运行 (CSR) 切向流过滤 (TFF) 系统的新型 TFF 系统,以大幅扩展为其生物工艺客户提供下游生产力。 ABEC 设备解决方案副总裁 Brady Cole 在一份声明中提到,传统的一次性 TFF 系统的流速要低得多,以避免爆裂。但他们的 CSR TFF 的流速超过每分钟 240 升,可以缩短达到高产品浓度的处理时间。
生物製药和生物製剂对全球切向流过滤(TFF)市场的增长产生重大影响。生物製药和生物製剂需要高效、可靠的纯化工艺,以确保它们对患者安全有效。 TFF 是生物製药和生物製品纯化最常用的方法之一,这推动了对 TFF 系统的需求。生物製药和生物製剂的复杂性推动了 TFF 技术的创新,从而导致新的和改进的 TFF 系统的开发。这些系统旨在提高 TFF 工艺的效率、可扩展性和可靠性,这对于生物製药和生物製剂的生产至关重要。在慢性病患病率上升和人口老龄化的推动下,生物製药行业正在快速增长。这种增长推动了对 TFF 系统的需求,因为生物製药製造商需要高效且经济高效的纯化工艺。新生物製药和生物製剂的开发需要广泛的研究和开发,这推动了对 TFF 系统的需求。 TFF 对于小分子的纯化至关重要,使其成为生物製药研究和开发的重要技术。过去几年,多种 COVID-19 疫苗的开发和批准一直是生物製品行业的主要焦点。多种疫苗已使用不同平台(包括 mRNA 和病毒载体技术)开发出来,并已在许多国家获得紧急使用授权。过去几年已经批准了几种新的基因疗法,包括用于治疗脊髓性肌萎缩症的基因疗法 Zolgensma 和用于治疗遗传性视网膜营养不良的基因疗法 Luxturna。基因疗法使用经过修饰的病毒将缺陷基因的功能副本传递给患有遗传病的患者。 CAR-T 细胞疗法是一种免疫疗法,涉及修改患者自身的 T 细胞以瞄准并摧毁癌细胞。近年来,多种 CAR-T 细胞疗法已获得批准,包括 Kymriah 和 Yescarta,用于治疗某些类型的白血病和淋巴瘤。
生物製药和生物製剂的复杂性推动了 TFF 技术的创新,从而导致新的和改进的 TFF 系统的开发。这些系统旨在提高 TFF 工艺的效率、可扩展性和可靠性,这对于生物製药和生物製剂的生产至关重要。 TFF 技术的创新是开发能够提高 TFF 系统效率和性能的新材料和膜。例如,使用具有改进的抗污染性和选择性的高性能聚合物膜可以带来更高的通量和更有效的目标分子分离。这些创新可以使 TFF 技术对生物製药公司和其他需要高纯度分离的行业更具吸引力。 TFF 技术的创新是开发更加自动化、高效且更具成本效益的新型 TFF 系统。例如,使用微流体装置、自动化控制系统和集成传感器可以提高 TFF 分离的精度和重现性,同时还可以减少执行这些分离所需的时间和成本。这些创新可以使 TFF 技术更容易为更广泛的用户所使用,从小型生物技术初创公司到大型製药公司。
研究活动在全球切向流过滤 (TFF) 市场的增长中发挥着重要作用。研究活动对于确定 TFF 新应用至关重要。随着研究人员更好地了解 TFF 的功能和局限性,他们可以为该技术开发新的创新应用,从而带来新的市场机会。研究活动可以通过确定特定应用的最佳膜材料、几何形状和操作条件来帮助优化 TFF 工艺。这使得 TFF 流程更加高效、有效,从而降低成本并提高性能。研究活动推动了 TFF 技术的创新,从而开发了新的和改进的 TFF 系统。这些系统的设计更加高效、可扩展且可靠,从而提高了 TFF 在生物製药行业的采用和使用。研究活动可以帮助研究人员更好地了解 TFF 背后的机制,从而改进过程控制和优化。这使得 TFF 流程更加高效、有效,从而降低成本并提高性能。研究活动通常涉及学术机构、行业和政府之间的合作和知识共享。这种合作可以促进新的 TFF 应用和技术的开发,并加深对 TFF 机制的理解。
政府的支持可以在全球切向流过滤(TFF)市场的增长中发挥重要作用。政府可以为TFF技术的研发提供资金。这可以促进新的和改进的 TFF 系统和应用的开发,推动市场的创新和增长。政府可以为 TFF 系统和应用制定法规和指南,确保 TFF 流程的安全性和有效性。清晰一致的法规还可以减少新参与者进入市场的壁垒。政府可以为 TFF 技术的商业化提供支持,例如为投资 TFF 研发的公司提供税收优惠或补助。这可以激励公司投资 TFF 技术,从而增加生物製药行业对该技术的采用和使用。政府可以投资基础设施来支持 TFF 市场的增长,例如为 TFF 製造设施的建设或现有设施的升级提供资金。这可以提高 TFF 生产能力,降低成本并提高效率。各国政府可以谈判国际贸易协定,以减少 TFF 技术和产品的进出口壁垒。这可以扩大 TFF 公司的市场覆盖范围,从而在全球范围内增加该技术的采用和使用。
根据给定的市场数据,TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项:
The Global Tangential Flow Filtration Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising advantages of tangential flow filtration over normal flow filtration, along with the increasing adoption of single-use technologies and growing research and development in pharma and biotech companies. Also, the growing usage of the TFF technology in different downstream processes is expected to drive the growth of the market during the forecast period. Additionally, the advantages of tangential flow filtration (TFF) for using as a high-performance and reproducible operation in biotechnology research and increasing investments for the development of novel TFF products by major companies are driving the growth of the market during the forecast period. In September 2021, ABEC, a dominant player that delivers single-use integrated solutions & services for biopharmaceutical manufacturing, announced the launch of their new TFF system called Custom Single Run (CSR) Tangential Flow Filtration (TFF) system, in order to appreciably expand downstream productivity for their bioprocess customers. Brady Cole, the VP of Equipment Solutions at ABEC, mentioned in a statement that traditional single-use TFF systems are cramped to a much lower flow rate so as to avoid bursting. But their CSR TFF having flow rates of more than 240 liters per minute makes process times shorter to attain high product concentrations.
Biopharmaceuticals and biologics have a significant impact on the growth of the global tangential flow filtration (TFF) market. Biopharmaceuticals and biologics require highly efficient and reliable purification processes to ensure that they are safe and effective for patients. TFF is one of the most commonly used methods for the purification of biopharmaceuticals and biologics, which is driving the demand for TFF systems. The complexity of biopharmaceuticals and biologics has driven innovation in TFF technology, leading to the development of new and improved TFF systems. These systems are designed to improve the efficiency, scalability, and reliability of the TFF process, which is essential for the production of biopharmaceuticals and biologics. The biopharmaceutical industry is growing rapidly, driven by the increasing prevalence of chronic diseases and the aging population. This growth is driving the demand for TFF systems as biopharmaceutical manufacturers require efficient and cost-effective purification processes. The development of new biopharmaceuticals and biologics requires extensive research and development, which drives the demand for TFF systems. TFF is essential for the purification of small molecules, making it an essential technology for biopharmaceutical research and development. The development and approval of several COVID-19 vaccines have been a major focus in the biologics industry in the past few years. Multiple vaccines have been developed using different platforms, including mRNA and viral vector technologies, and have been authorized for emergency use in many countries. There have been several new gene therapies approved in the past few years, including Zolgensma, a gene therapy for spinal muscular atrophy, and Luxturna, a gene therapy for inherited retinal dystrophy. Gene therapies use modified viruses to deliver a functional copy of a defective gene to patients with genetic diseases. CAR-T cell therapies are a type of immunotherapy that involves modifying a patient's own T-cells to target and destroy cancer cells. Several CAR-T cell therapies have been approved in recent years, including Kymriah and Yescarta, which are used to treat certain types of leukemia and lymphoma.
The complexity of biopharmaceuticals and biologics has driven innovation in TFF technology, leading to the development of new and improved TFF systems. These systems are designed to improve the efficiency, scalability, and reliability of the TFF process, which is essential for the production of biopharmaceuticals and biologics. Innovation in TFF technology is the development of new materials and membranes that can improve the efficiency and performance of TFF systems. For example, the use of high-performance polymeric membranes with improved fouling resistance and selectivity can lead to higher throughput and more efficient separation of target molecules. These innovations can make TFF technology more attractive to biopharmaceutical companies and other industries that require high-purity separations. Innovation in TFF technology is the development of new TFF systems that are more automated, efficient, and cost-effective. For example, the use of microfluidic devices, automated control systems, and integrated sensors can improve the precision and reproducibility of TFF separations while also reducing the time and cost required to perform these separations. These innovations can make TFF technology more accessible to a wider range of users, from small biotech startups to large pharmaceutical companies.
Research activities play a significant role in the growth of the global tangential flow filtration (TFF) market. Research activities are essential for identifying new applications for TFF. As researchers better understand the capabilities and limitations of TFF, they can develop new and innovative applications for the technology, leading to new market opportunities. Research activities can help optimize TFF processes by identifying the best membrane materials, geometries, and operating conditions for specific applications. This leads to more efficient and effective TFF processes, reducing costs and improving performance. Research activities drive innovation in TFF technology, leading to the development of new and improved TFF systems. These systems are designed to be more efficient, scalable, and reliable, leading to increased adoption and use of TFF in the biopharmaceutical industry. Research activities can help researchers better understand the mechanisms behind TFF, leading to improved process control and optimization. This leads to more efficient and effective TFF processes, reducing costs and improving performance. Research activities often involve collaboration and knowledge sharing between academic institutions, industry, and government. This collaboration can lead to the development of new TFF applications and technologies, as well as an improved understanding of TFF mechanisms.
Government support can play a significant role in the growth of the global tangential flow filtration (TFF) market. Governments can provide funding for the research and development of TFF technology. This can lead to the development of new and improved TFF systems and applications, driving innovation and growth in the market. Governments can establish regulations and guidelines for TFF systems and applications, ensuring the safety and efficacy of TFF processes. Clear and consistent regulations can also reduce barriers to entry for new players in the market. Governments can provide support for the commercialization of TFF technology, such as tax incentives or grants for companies that invest in TFF research and development. This can incentivize companies to invest in TFF technology, leading to increased adoption and use of the technology in the biopharmaceutical industry. Governments can invest in infrastructure to support the growth of the TFF market, such as funding for the construction of TFF manufacturing facilities or upgrades to existing facilities. This can increase the capacity for TFF production, reducing costs and increasing efficiency. Governments can negotiate international trade agreements that reduce barriers to the export and import of TFF technology and products. This can increase the market reach of TFF companies, leading to increased adoption and use of the technology globally.
Global Tangential Flow Filtration market can be segmented by product, membrane material, technique, application, end-user, region, and competitive landscape. Based on the product, the market can be segmented into Single Use Systems, Reusable Systems, Membrane Filters, and Filtration Accessories. Based on membrane material, the market can be segmented into PES, Polyvinylidene Difluoride, Nylon, PTFE, Mixed cellulose ester & cellulose acetate, PCTE, Regenerated Cellulose, and Other membrane materials. Based on the technique, the market can be differentiated into Microfiltration, Ultrafiltration, Nanofiltration, and Other Techniques. Based on application, the market can be segmented into Final product processing, Raw material filtration, Cell separation, Water purification, and Air purification. Based on the end user, the market can be differentiated into Pharmaceutical & Biotechnology companies, Contract research organizations, and Academic & Research institutes. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominates the Global Tangential Flow Filtration Market on account of the growing well-developed laboratories in the country.
Merck KGAA., Danaher Corporation, Sartorius AG, Parker Hannifin Corporation, Repligen Corporation, Alfa Laval Corporate AB., Andritz, Meissner Filtration Products Inc., Cole Parmer Instrument Company Inc., and Sterlitech Corporation are some of the leading players operating in the Global Tangential Flow Filtration Market.
In this report, Global Tangential Flow Filtration Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Tangential Flow Filtration Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: